Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis
暂无分享,去创建一个
Dirk Repsilber | Stefan H. E. Kaufmann | Andreas Ziegler | A. Ziegler | H. Mollenkopf | S. Kaufmann | M. Jacobsen | D. Repsilber | A. Gutschmidt | A. Neher | K. Feldmann | Marc Jacobsen | Andrea Gutschmidt | Hans J. Mollenkopf | Albert Neher | Knut Feldmann
[1] A. Kalita,et al. Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. , 2004, The Journal of infectious diseases.
[2] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[3] A. Krensky,et al. T-cell release of granulysin contributes to host defense in leprosy , 2001, Nature Medicine.
[4] D G Altman,et al. What do we mean by validating a prognostic model? , 2000, Statistics in medicine.
[5] A. Ziegler,et al. Deconfounding microarray analysis - independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. , 2006, Methods of information in medicine.
[6] Philip M Murphy,et al. Formyl-peptide receptors revisited. , 2002, Trends in immunology.
[7] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[8] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[9] C. Rubel,et al. N-Formyl-Methionyl-Leucyl-Phenylalanine Inhibits both Gamma Interferon- and Interleukin-10-Induced Expression of FcγRI on Human Monocytes , 2001, Clinical Diagnostic Laboratory Immunology.
[10] S. Kaufmann,et al. Correction of the Iron Overload Defect in β-2-Microglobulin Knockout Mice by Lactoferrin Abolishes Their Increased Susceptibility to Tuberculosis , 2002, The Journal of experimental medicine.
[11] O. Conneely,et al. Lactoferrin and host defense. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[12] Marino Zerial,et al. Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.
[13] R. Tibshirani,et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.
[14] T. van der Poll,et al. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. , 1998, The Journal of infectious diseases.
[15] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[16] R. Snyderman,et al. Chemoattractant receptors on phagocytic cells. , 1984, Annual review of immunology.
[17] N. Hibler,et al. Arrest of Mycobacterial Phagosome Maturation Is Caused by a Block in Vesicle Fusion between Stages Controlled by rab5 and rab7* , 1997, The Journal of Biological Chemistry.
[18] R. Modlin,et al. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. , 2002, Current opinion in immunology.
[19] Bernhard Hemmer,et al. A point mutation in PTPRC is associated with the development of multiple sclerosis , 2000, Nature Genetics.
[20] Stefan H E Kaufmann,et al. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis , 2005, Nature Medicine.
[21] J. V. D. van de Winkel,et al. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. , 1993, Immunology today.
[22] A. Ziegler,et al. Ras-associated small GTPase 33A, a novel T cell factor, is down-regulated in patients with tuberculosis. , 2005, The Journal of infectious diseases.
[23] Y. H. Chan. Biostatistics 303. Discriminant analysis. , 2005, Singapore medical journal.
[24] Javed Khan,et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.
[25] C. Figdor,et al. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. , 1992, Journal of immunology.
[26] S. Kaufmann,et al. How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.
[27] C. Nathan,et al. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. , 2000, Current opinion in microbiology.
[28] G. Vanham,et al. Generalized immune activation in pulmonary tuberculosis: co‐activation with HIV infection , 1996, Clinical and experimental immunology.
[29] G. Khuller,et al. Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. , 2000, The European respiratory journal.
[30] J. Flynn,et al. Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.